Minerva Neurosciences receives Nasdaq deficiency notice for bid price below $1.00

Minerva Neurosciences, Inc.

Nasdaq letter dated Jan 12, 2022, for closing bid price below $1.00 for 30 consecutive business days.
Company has 180 calendar days (until July 11, 2022) to regain compliance.
Compliance requires closing bid price ≥$1.00 for at least ten consecutive business days.
Common stock continues trading on Nasdaq Global Market under symbol NERV; no immediate delisting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.